Magnetic resonance imaging for primary breast cancer management: current role and new applications.

2002 ◽  
pp. 141-153 ◽  
Author(s):  
L Esserman ◽  
D Wolverton ◽  
N Hylton
Keyword(s):  
Breast Cancer ◽  
Magnetic Resonance ◽  
Mr Imaging ◽  
Mr Images ◽  
Cancer Management ◽  
The Past ◽  
Breast Cancer Management ◽  
Clinical Breast ◽  
Unnecessary Procedures ◽  
New Applications

Techniques for magnetic resonance (MR) imaging of the breast have been evolving over the past decade. The opportunities for integration of MR imaging into clinical breast cancer management and clinical research are increasing. In this paper, we will review the principles behind the creation of standard and MR images and use this as a platform to evaluate clinical studies and indications for the use and study of MR. In particular, we will focus on those areas where MR has the capability of changing care and/or improving our understanding of the biology of breast cancer. In addition, we will address areas where MR is not yet capable of adding value or where MR may lead to unnecessary procedures.

scholarly journals Management of Breast Cancer in Nepal

2009 ◽  
Vol 48 (175) ◽  
Author(s):  
Yogendra P Singh ◽  
P Sayami
Keyword(s):  
Breast Cancer ◽  
Early Detection ◽  
Cancer Education ◽  
Tumor Biology ◽  
Metastatic Breast ◽  
Premenopausal Women ◽  
Clinical Breast Examination ◽  
Cancer Management ◽  
Breast Cancer Management ◽  
Clinical Breast

Breast cancer is the second most common malignancy among women in Nepal. It is more commonin young premenopausal women. Breast cancer continues to increase in incidence due to lifestylechanges in Nepalese women despite constant remarkable development in the management of thisdisease over the past three decades. Breast cancer was diagnosed solely clinically and surgery wasthe only treatment option until fi fty years ago. Multidisciplinary approach has been adopted fordiagnosis and treatment of breast cancer in Nepal. Imaging is required for the diagnosis, appropriatetreatment decision and proper follow up. Treatment modality depends upon the extent of thedisease and tumor biology. However, there is a strong need for standard guidelines for the propermanagement of breast cancer in Nepal so that surgeries, chemotherapy, hormone therapy andradiotherapy are standardized in the country. Palliative care has been initiated to provide to somepatients with metastatic breast cancer recently.The breast cancer management in Nepal is a little different when compared with the centers in thedeveloped countries. The reasons are socioeconomic status, lack of education and lack of facilities.Although cancer care is on the rise in Nepal, the optimal facility for centers managing breast cancerhas to be improved signifi cantly.Cancer education, screening and early detection are the keyelements to infl uence the diagnosis, treatment and prognosis of breast cancer in Nepal. Breast cancerawareness and clinical breast examination are important tools for early detection in our resourcelimited context. Breast cancer can be cured in majority of the cases if diagnosed in early stages.This review will focus on relevant patient data along with future recommendation regarding breastcancer treatment in Nepal.Key Words: Breast cancer, cancer education, chemotherapy, imaging, radiotherapy, surgery

scholarly journals Targeted therapeutic options and future perspectives for HER2-positive breast cancer

2019 ◽  
Vol 4 (1) ◽  
Author(s):  
Jiani Wang ◽  
Binghe Xu
Keyword(s):  
Breast Cancer ◽  
Growth Factor Receptor ◽  
Clinical Practices ◽  
Her2 Positive ◽  
Cancer Management ◽  
The Past ◽  
Her2 Positive Breast Cancer ◽  
Clinical Scenarios ◽  
Breast Cancer Management ◽  
Positive Breast Cancer

Abstract Over the past 2 decades, there has been an extraordinary progress in the regimens developed for the treatment of human epidermal growth factor receptor 2 (HER2)-positive breast cancer. Trastuzumab, pertuzumab, lapatinib, and ado-trastuzumab emtansine (T-DM1) are commonly recommended anti-HER2 target agents by the U.S. Food and Drug Administration. This review summarizes the most significant and updated research on clinical scenarios related to HER2-positive breast cancer management in order to revise the guidelines of everyday clinical practices. In this article, we present the data on anti-HER2 clinical research of neoadjuvant, adjuvant, and metastatic studies from the past 2 decades. We also highlight some of the promising strategies that should be critically considered. Lastly, this review lists some of the ongoing clinical trials, findings of which may soon be available.

scholarly journals Role of magnetic resonance imaging in breast cancer management

2018 ◽  
Vol 07 (02) ◽  
pp. 069-071 ◽  
Author(s):  
Selvi Radhakrishna ◽  
S. Agarwal ◽  
Purvish M. Parikh ◽  
K. Kaur ◽  
Shikha Panwar ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Magnetic Resonance Imaging ◽  
High Risk ◽  
Magnetic Resonance ◽  
Breast Mri ◽  
Average Risk ◽  
Resonance Imaging ◽  
Cancer Management ◽  
Breast Cancer Management ◽  
Magnetic Resonance Imaging Mri

AbstractMagnetic resonance imaging (MRI) of the breast is primarily used as a supplemental tool to breast screening with mammography or ultrasound. A breast MRI is mainly used for women who have been diagnosed with breast cancer, to help measure the size of the cancer, look for other tumors in the breast, and to check for tumors in the opposite breast. For certain women at high risk for breast cancer, a screening MRI is recommended along with a yearly mammogram. MRI is known to give some false positive results which mean more test and/or biopsies for the patient. Thus, although breast MRI is useful for women at high risk, it is rarely recommended as a screening test for women at average risk of breast cancer. Also, breast MRI does not show calcium deposits, known as micro-calcifications which can be a sign of breast cancer.

Antiangiogenic strategies in breast cancer management

2010 ◽  
Vol 76 (1) ◽  
pp. 13-35 ◽  
Author(s):  
Monica Giovannini ◽  
Daniela Aldrighetti ◽  
Patrizia Zucchinelli ◽  
Carmen Belli ◽  
Eugenio Villa
Keyword(s):  
Breast Cancer ◽  
Cancer Management ◽  
Breast Cancer Management

scholarly journals Breast cancer management in low resource countries (LRCs): Consensus statement from the Breast Health Global Initiative

The Breast ◽  
2011 ◽  
Vol 20 ◽  
pp. S3-S11 ◽  
Author(s):  
Nagi S. El Saghir ◽  
Clement A. Adebamowo ◽  
Benjamin O. Anderson ◽  
Robert W. Carlson ◽  
Peter A. Bird ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Consensus Statement ◽  
Breast Health ◽  
Low Resource ◽  
Cancer Management ◽  
Breast Cancer Management ◽  
Global Initiative
Sign in / Sign up

Export Citation Format

Share Document